Belongs to

• Solid Tumor Oncology Division

Types of Work

["2018"]

[[["Journal Articles",258],["Meeting Abstracts",225],["Book Sections",5],["Books Whole",1]]]

[489]

Popular keywords

• adult
• aged
• article
• clinical article
• controlled study
• female
• human
• major clinical study
• male
• priority journal

Recent Works

1. Efficacy and safety of ripretinib as >= 4th-line therapy for patients with gastrointestinal stromal tumor following crossover from placebo: Analyses from INVICTUS

   Meeting Abstract

   Serrano, C.; Heinrich, M.; George, S.; Zalcberg, J.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Jones, R.; Attia, S.; D'Amato, G.; more...
   Annals of Oncology (2020)

   Fulltext@MSK | Save
2. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): A double-blind, randomised, placebo-controlled, phase 3 trial

   Journal Article

   Blay, J. Y.; Serrano, C.; Heinrich, M. C.; Zalcberg, J.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
   Lancet Oncology (2020)

   Fulltext@MSK | Save
3. Characterization of on-target adverse events caused by TRK inhibitor therapy

   Journal Article

   Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
   Annals of Oncology (2020)

   Fulltext@MSK | Save